JP2022531570A5 - - Google Patents
Info
- Publication number
- JP2022531570A5 JP2022531570A5 JP2021564186A JP2021564186A JP2022531570A5 JP 2022531570 A5 JP2022531570 A5 JP 2022531570A5 JP 2021564186 A JP2021564186 A JP 2021564186A JP 2021564186 A JP2021564186 A JP 2021564186A JP 2022531570 A5 JP2022531570 A5 JP 2022531570A5
- Authority
- JP
- Japan
- Prior art keywords
- days
- body weight
- approximately
- alkylene
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/085209 | 2019-04-30 | ||
| CN2019085209 | 2019-04-30 | ||
| PCT/CN2020/087689 WO2020221277A1 (zh) | 2019-04-30 | 2020-04-29 | 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531570A JP2022531570A (ja) | 2022-07-07 |
| JP2022531570A5 true JP2022531570A5 (enExample) | 2023-05-11 |
| JP7663508B2 JP7663508B2 (ja) | 2025-04-16 |
Family
ID=73028778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564186A Active JP7663508B2 (ja) | 2019-04-30 | 2020-04-29 | ジアミノピリミジン化合物を使用することによって、子宮内膜症性疼痛を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12605381B2 (enExample) |
| EP (1) | EP3960178B1 (enExample) |
| JP (1) | JP7663508B2 (enExample) |
| KR (1) | KR102935431B1 (enExample) |
| CN (1) | CN114007620B (enExample) |
| AU (1) | AU2020266947B2 (enExample) |
| BR (1) | BR112021021838A8 (enExample) |
| CA (1) | CA3138238A1 (enExample) |
| MX (1) | MX2021013347A (enExample) |
| SG (1) | SG11202111960PA (enExample) |
| TW (1) | TWI737285B (enExample) |
| WO (1) | WO2020221277A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
| WO2023081800A1 (en) * | 2021-11-05 | 2023-05-11 | The Regents Of The University Of California | Alpha-2a adrenergic receptor modulators and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
| WO2017160569A1 (en) | 2016-03-14 | 2017-09-21 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| AU2017237929B2 (en) * | 2016-03-25 | 2021-04-15 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
-
2020
- 2020-04-29 EP EP20798599.5A patent/EP3960178B1/en active Active
- 2020-04-29 AU AU2020266947A patent/AU2020266947B2/en active Active
- 2020-04-29 MX MX2021013347A patent/MX2021013347A/es unknown
- 2020-04-29 WO PCT/CN2020/087689 patent/WO2020221277A1/zh not_active Ceased
- 2020-04-29 KR KR1020217038622A patent/KR102935431B1/ko active Active
- 2020-04-29 BR BR112021021838A patent/BR112021021838A8/pt unknown
- 2020-04-29 CN CN202080032509.8A patent/CN114007620B/zh active Active
- 2020-04-29 US US17/607,475 patent/US12605381B2/en active Active
- 2020-04-29 JP JP2021564186A patent/JP7663508B2/ja active Active
- 2020-04-29 CA CA3138238A patent/CA3138238A1/en active Pending
- 2020-04-29 SG SG11202111960PA patent/SG11202111960PA/en unknown
- 2020-04-30 TW TW109114698A patent/TWI737285B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522486A5 (enExample) | ||
| ES2617628T3 (es) | Régimen de dosificación para un agonista selectivo del receptor de S1P1 | |
| US20070112067A1 (en) | Nitrosated and nitrosylated prostaglandins, compositions and methods of use | |
| JP2022539329A5 (enExample) | ||
| CN1255854A (zh) | 1,2,4－三唑并[1,5－c]嘧啶杂环类似物在制备用于治疗心血管疾病的药物中的用途 | |
| US6476074B1 (en) | Method and composition for treatment of erectile dysfunction | |
| WO2008070795A2 (en) | Combination therapy using low-dose doxepin for the improvement of sleep | |
| US20100093754A1 (en) | Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders | |
| CZ20012459A3 (cs) | Léčivo pro léčení sexuálních poruch u lidí | |
| RU2010123028A (ru) | Кортикостероиды для лечения диареи, индуцированной эпотилоном или производным эпотилона | |
| HU208076B (en) | Process for producting pharmaceutical composition suitable for treating impotence | |
| JP2012525437A5 (enExample) | ||
| JP2022531570A5 (enExample) | ||
| RU2003105159A (ru) | Способ лечения климактерических расстройств у женщин во время или после менопаузы | |
| JP2018138594A (ja) | オナプリストン多形体及び使用方法 | |
| US10195187B2 (en) | Oxybutynin-xanomeline transdermal therapeutic system combinations | |
| DK2555776T3 (en) | Combination Compositions of Adenosine A1 Agonists and Non-Selective Beta-Adrenoreceptor Blockers to Reduce Intraocular Pressure | |
| JP2011512399A (ja) | 卵巣癌を治療するための、パクリタキセルを含む配合剤 | |
| CN102933220A (zh) | 用于降低眼内压的腺苷a1激动剂与碳酸酐酶抑制剂的组合型组合物 | |
| CA2915814A1 (en) | Local use of pentoxifylline to treat peyronie's disease | |
| JP6691193B2 (ja) | プロゲステロン受容体アンタゴニスト剤形 | |
| JP7663508B2 (ja) | ジアミノピリミジン化合物を使用することによって、子宮内膜症性疼痛を治療する方法 | |
| JP2023527358A (ja) | 肺線維症を処置する方法 | |
| JP2022530890A5 (enExample) | ||
| JP2007506784A (ja) | 双極性障害およびその他の認知障害の治療における、ケレリトリン、その類似体およびそれらの使用 |